Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NDFIP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
mRNA | OSBP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ITIH6 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | CKAP5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | KRT7 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
mRNA | CLDN1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
mRNA | GPCPD1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | DZIP1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
mRNA | IL36G | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | FAM189A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |